Year: 2020
Journal: J. Pharm. Sci., Volume 109, JAN, page 633–639
Authors: Larson, NR; Wei, YJ; Prajapati, I; Chakraborty, A; Peters, B; Kalonia, C; Hudak, S; Choudhary, S; Esfandiary, R; Dhar, P; Schoneich, C; Middaugh, CR
Organizations: MedImmune, Inc.AstraZeneca
Keywords: antibody(s); protein aggregation; surfactant(s); degradation product(s); formulation; lipid(s)